The Food and Drug Administration on Friday approved Zavzpret, a new nasal spray designed to treat migraines in just 15 minutes. The drug, which Pfizer acquired when it bought out Biohaven ...

This rainy weather plus the incoming holiday stress can trigger migraines. But there’s a brand new medicine available for ...

FBI agents remained on the scene more than 24 hours after an agent-involved shooting at a home in the Northland. The 86-year-old man charged in the April 2023 shooting of Ralph Yarl will have ...

Inclusion and exclusion criteria were as defined in the zolmitriptan product label; patients diagnosed with migraine and prescribed zolmitriptan nasal spray by participating physicians were ...

Naloxone HCl 4mg; per spray; contains benzalkonium chloride. Naloxone hydrochloride antagonizes opioid effects by competing for the same receptor sites. It reverses the effects of opioids ...

A new PDUFA target date is April 30, 2025. The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for STS101 (dihydroergotamine [DHE] nasal ...

Conclusions: The rapid absorption of zolmitriptan nasal spray may explain the faster relief from migraine reported in patients compared with oral zolmitriptan.